In June 2024, tirzepatide (Zepbound, Mounjaro) was added to the FAAs Acceptable Weight Loss Medications category, clearing the path to general eligibility medical certification for pilots and ATCS
As always, patients should keep a balanced perspective when considering side effects of any medication
Critically, a positive feedback loop emerges between accumulated long-chain acylcarnitines and excessive ROS: these acylcarnitines inhibit electron transport chain complex III, inducing ROS overproduction, whereas ROS suppresses CPT2 activity, preventing further metabolism of long-chain acylcarnitines [55, 135,136,137,138]
The combination is the point
Trial evidence supports serious interest in its weight-loss effects, but food noise is a subjective experience, not a guarantee you can safely infer from social media claims or peptide-site marketing
This is one reason people sometimes stop losing weight without changing anything, degraded medication delivering less drug than expected